Stay updated on CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Sign up to get notified when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.

Latest updates to the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe page’s revision label changed from v3.5.3 to v3.5.4, indicating a minor metadata update to the page.SummaryDifference0.0%

- Check16 days agoChange DetectedThe Taiwan site entry in the study's locations list now uses 'Taoyuan City, Taiwan' instead of 'Taoyuan, Taiwan', clarifying the exact city designation used for that site.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe footer revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check73 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check101 days agoChange DetectedResults Submitted appears and a new revision (v3.4.2) is listed; the 'No Results Posted' notice was removed.SummaryDifference0.3%

Stay in the know with updates to CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.